Atlas Trials

Macitentan in Pulmonary Hypertension of Sickle Cell Disease

Clinical trial NCT02651272 · TERMINATED

Trial details

NCT number
NCT02651272
Sponsor
Boston University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Pulmonary HypertensionSickle Cell Disease
Start date
2015-07-01
Primary completion
2019-12-18
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.